Send PM
Followers 28
Posts 1014
Boards Moderated 0
Alias Born 03/10/2014

Re: None

Thursday, 08/26/2021 11:29:06 AM

Thursday, August 26, 2021 11:29:06 AM

Post# of 4237
Another "Proposed Date" has come and gone again...and nothing from the company?

Seems that the communication problems that have plagued this company for the past 5+ years that I have been here are still happening. Typically companies learn from their mistakes, but apparently that is not the case with ADMP?

Now with another Quarterly report being missed...and nothing from the company, really makes you wonder what is going on behind the scenes?

If there is in fact a buy-out pending Zimhi FDA Approval, wouldn't that be a material event that would need to be shared with the stockholders?

If we have until November to regain NASDAQ compliance...and November is also when Zimhi FDA Approval is expected...is the company really just kicking the proverbial can down the road for financials and putting all the eggs in the "Buy-Out" basket?

I received no less than 5 letters from the company asking me to disregard Hammann's proposals regarding the reelection of the board of directors...but can't get a single letter to explain financials, or a single letter to explain the delay in starting Tempol trials?

Am I the only frustrated Long here?

In My Own Personal Opinion Of Course!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Recent ADMP News

FEATURED Worldwide Crypto Based Exchange Traded Products AUM Dropped 17% in November Dec 7, 2022 8:55 AM

Branded Legacy, Inc. Adds Subsidiary Bringing Additional $750,000 in Revenues BLEG Dec 7, 2022 8:00 AM

BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem Targeting Polycystic Ovary Syndrome as an Indication BRTX Dec 6, 2022 9:52 AM

Maison Luxe Announces Additional $250,000 Purchase Order from Signet International Group for Upcoming Holiday Season MASN Dec 6, 2022 8:10 AM

$10.97 Billion Potential Global Condom Market Could be a Key Driver of Growth for Israeli Cannabis Technology Company BYND Cannasoft Enterprises BYND Dec 5, 2022 8:00 AM

Electromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022 EMED Dec 5, 2022 7:15 AM

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Files EZ-G Patent Application to Include Double Faceted Condom BYND Dec 2, 2022 10:38 AM

Healixa Inc. Appoints Former Acting Secretary of Defense of The United States Christopher C. Miller to Its Advisory Board EMOR Dec 1, 2022 9:20 AM

Kona Gold Beverage, Inc's Gold Leaf Distribution Subsidiary Posts Record Revenue Month in November KGKG Dec 1, 2022 9:00 AM

Mullen Automotive Officially Closes on Acquisition of ELMS Assets, Takes Possession of Plant in Mishawaka, Ind., All Intellectual Property and Related Inventory MULN Dec 1, 2022 8:31 AM

HealthLynked Announces Points Reward Program for Online Medical Supplies Purchases HLYK Dec 1, 2022 8:00 AM

InnerScope Hearing Technologies (OTC: INND) Launches Its iHEAR Brand of OTC Hearing Aids on CVS.com INND Dec 1, 2022 8:00 AM

Aduro Announces Completion of Mechanical Assembly of its R2 Plastic Reactor ACT Dec 1, 2022 7:59 AM

Fission 3.0 Intersects Off-Scale Mineralization in the First Follow Up Hole at PLN A1 Discovery FUU Nov 30, 2022 8:21 AM

Healixa Expands Advisory Board with Appointment of Accomplished C-Level Executive with History of Accelerating Profitable Growth EMOR Nov 29, 2022 9:26 AM